• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis. Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers

tetano

Editor, Senior Moderator
J Infect Dis. 2020 Apr 22. pii: jiaa205. doi: 10.1093/infdis/jiaa205. [Epub ahead of print]
Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers.


Pan Y[SUP]1[/SUP], Yu X[SUP]1[/SUP], Du X[SUP]2[/SUP], Li Q[SUP]1[/SUP], Li X[SUP]3[/SUP], Qin T[SUP]4[/SUP], Wang M[SUP]5[/SUP], Jiang M[SUP]6[/SUP], Li J[SUP]7[/SUP], Li W[SUP]8[/SUP], Zhang Q[SUP]9[/SUP], Xu Z[SUP]10[/SUP], Zhang L[SUP]11[/SUP].

Author information




Abstract

BACKGROUND:

We retrospectively analysed 26 persistently asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) carriers.
METHODS:

Epidemiological and clinical characteristics from the 26 asymptomatic patients with positive results for SARS-CoV-2 RNA testing were obtained.
RESULTS:

Twenty-two patients (84.6%) correlated with clustering occurrence. The median period from contact to diagnosis and the last positive nucleic acid test was 19 (8-24 days) and 21.5 days (10-36 days), respectively. The median period from diagnosis to negative nucleic acid test was significantly different between patients with normal or atypical chest computed tomography (CT) findings (n=16, 61.5%; 7.5 days [2-20 days]) and patients with typical ground-glass or patchy opacities on CT(n=10, 38.5%; 12.5 days[8-22 days]; P<0.01). Seven patients (70.0%) with initial positive nucleic acid test results had a negative result simultaneously with improved CT findings. Obvious improvement in CT findings was observed in three patients (30.0%) despite positive nucleic acid test results.
CONCLUSION:

In asymptomatic patients, changes in biochemical and inflammatory variables are small and changes on chest CT can occur. It is worth noting the long existence of SARS-CoV-2 in some asymptomatic patients and false-negative results need to be considered in SARS-CoV-2nucleic acid test.
? The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.



KEYWORDS:

Coronavirus Disease 2019; Severe Acute Respiratory Syndrome Coronavirus 2; asymptomatic; clinical characteristics


PMID:32318703DOI:10.1093/infdis/jiaa205
 
Back
Top Bottom